Why the study?
Do alterations in catecholamine levels or thyroid activity prevent ventricular fibrillation during hypothermia in dogs?
Do alterations in catecholamine levels or thyroid activity prevent ventricular fibrillation during hypothermia in dogs?
In a canine model, protection against hypothermic ventricular fibrillation by reserpine or antithyroid interventions does not correlate with cardiac catecholamine depletion, pointing instead to depressed tissue metabolism.
Answers are grounded in this paper and cite their sources.
Questions catecholamine role in hypothermic VF; leaves open metabolic mechanisms for translational research.
The possible significance of endogenous catecholamines in the production of hypothermic ventricular fibrillation has been investigated.It is shown that in dogs under pentobarbitone anesthesia, neither iproniazid nor phenoxybenzamine pretreatment reduces the incidence of ventricular fibrillation following coronary occlusion during hypothermia. Reserpine pretreatment markedly reduced both the catecholamines content of the left ventricle and the incidence of ventricular fibrillation. This protective action of reserpine can be counteracted by combined pretreatment with liothyronine sodium, although the catecholamines of the heart remained at a low level. Conversely, thyroidectomy and methimazole treatment also greatly reduced the incidence of ventricular fibrillation without significantly reducing cardiac catecholamines. These experiments reveal no correlation between the ventricular catecholamines content and the incidence of ventricular fibrillation. It is suggested that the protective effects of reserpine and thyroidectomy or antithyroid treatment might be due to depression of tissue metabolism.
No takes yet. Share an insight, caveat, or question.
Varma et al. (1963) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: